Send to

Choose Destination
Proc (Bayl Univ Med Cent). 2013 Jul;26(3):314-9.

Clinical utility of positron emission mammography.

Author information

Department of Radiology, Baylor University Medical Center at Dallas.


Several imaging modalities have been introduced over recent years to better screen for and stage breast cancer. Positron emission mammography (PEM) has been approved by the US Food and Drug Administration and introduced into clinical use as a diagnostic adjunct to mammography and breast ultrasonography. PEM has higher resolution and a more localized field of view than positron emission tomography-computed tomography and can be performed on patients to stage a newly diagnosed malignancy. Review of mammograms together with magnetic resonance or PEM images improves detection of disease.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center